Literature DB >> 7230332

Prognostic factors in carcinoma of the ureter.

N M Heney, B N Nocks, J J Daly, P H Blitzer, E C Parkhurst.   

Abstract

The records and pathological slides of 60 patients with ureteral cancer were reviewed with particular attention being paid to the tumor-adjacent mucosa. Mucosal abnormalities increased as grade and stage increased but their presence did not correlate with survival nor with the presence of urothelial tumors elsewhere, that is previous, concomitant and subsequent tumors. Patients with papillary and solid tumors survived equally well. Survival among patients with stage B tumors was better than that reported previously (82 per cent survived 5 years).

Entities:  

Mesh:

Year:  1981        PMID: 7230332     DOI: 10.1016/s0022-5347(17)55143-5

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  11 in total

1.  High-grade invasive urothelial carcinoma of the ureter with systematic lymph node metastasis successfully treated by nephroureterectomy followed by chemotherapy.

Authors:  Zhu-Qing Liu; Xi Zhang; Qing Xu
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Genetic Variations in Glutathione Pathway Genes Predict Cancer Recurrence in Patients Treated with Transurethral Resection and Bacillus Calmette-Guerin Instillation for Non-muscle Invasive Bladder Cancer.

Authors:  Hung-Lung Ke; Jie Lin; Yuanqing Ye; Wen-Jeng Wu; Hui-Hui Lin; Hua Wei; Maosheng Huang; David W Chang; Colin P Dinney; Xifeng Wu
Journal:  Ann Surg Oncol       Date:  2015-04-08       Impact factor: 5.344

3.  Treatment of upper tract urothelial carcinoma: a review of surgical and adjuvant therapy.

Authors:  Kalyan C Latchamsetty; Christopher R Porter
Journal:  Rev Urol       Date:  2006

4.  Factors affecting the survival of patients treated by standard nephroureterectomy for transitional cell carcinoma of the upper urinary tract.

Authors:  Suleyman Ataus; Bulent Onal; Burcin Tunc; Ahmet Erozenci; Arman Cekmen; Ali Riza Kural; Armagan Oner
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

5.  Patterns of failure and influence of potential prognostic factors after surgery in transitional cell carcinoma of the upper urinary tract.

Authors:  Tatsuya Shimomura; Norishige Ohtsuka; Hiroki Yamada; Jun Miki; Norihiro Hayashi; Takahiro Kimura; Hidetoshi Kuruma; Shin Egawa
Journal:  Int J Clin Oncol       Date:  2009-07-11       Impact factor: 3.402

6.  Genetic variations in micro-RNA biogenesis genes and clinical outcomes in non-muscle-invasive bladder cancer.

Authors:  Hung-Lung Ke; Meng Chen; Yuanqing Ye; Michelle A T Hildebrandt; Wen-Jeng Wu; Hua Wei; Maosheng Huang; David W Chang; Colin P Dinney; Xifeng Wu
Journal:  Carcinogenesis       Date:  2013-01-14       Impact factor: 4.944

7.  Results of adjuvant chemotherapy for invasive uroepithelial cancer.

Authors:  Y Uekado; A Hirano; T Shinka; T Ohkawa
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

8.  Clinical analysis of ureteral tumours with or without renal pelvic neoplasms.

Authors:  T Nakada; K Umeda; H Koike; T Akiya; T Katayama
Journal:  Int Urol Nephrol       Date:  1987       Impact factor: 2.370

9.  Prognostic factors in transitional cell carcinoma of the upper urinary tract after radical nephroureterectomy.

Authors:  Dae Sung Cho; Seok Young Hong; Young Kyun Kim; Sun Il Kim; Se Joong Kim
Journal:  Korean J Urol       Date:  2011-05-24

10.  Comprehensive management of upper tract urothelial carcinoma.

Authors:  Georgios Koukourakis; Georgios Zacharias; Michael Koukourakis; Kiriaki Pistevou-Gobaki; Christos Papaloukas; Athanasios Kostakopoulos; Vassilios Kouloulias
Journal:  Adv Urol       Date:  2008-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.